![Shelley McCloskey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shelley McCloskey
Responsable des Ressources Humaines chez XENON PHARMACEUTICALS INC.
Provenance du réseau au premier degré de Shelley McCloskey
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 25 | |
Aquinox Pharmaceuticals, Inc.
![]() Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada.
8
| Extinct | Pharmaceuticals: Major | 8 |
Xantrex Technology, Inc.
![]() Xantrex Technology, Inc. SemiconductorsElectronic Technology Xantrex Technology, Inc. manufactures power supplies. It specializes in charger and inverter, power inverter, battery charger and backup power. The company is headquartered in Burnaby, Canada.
5
| Subsidiary | Semiconductors | 5 |
1322256 Alberta Ltd.
![]() 1322256 Alberta Ltd. Pharmaceuticals: MajorHealth Technology Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer.
1
| Extinct | Pharmaceuticals: Major | 1 |
Public Company | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Shelley McCloskey via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of British Columbia | College/University | Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin Undergraduate Degree Masters Business Admin Undergraduate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | President Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor | |
ALECTOR, INC. | Biotechnology | Director/Board Member Director/Board Member | |
LifeSciences British Columbia
![]() LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman Director/Board Member | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member | |
INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Northeastern University
![]() Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Masters Business Admin | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AQUESTIVE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Consultant / Advisor | |
EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Chairman Corporate Officer/Principal | |
The Centre for Drug Research & Development
![]() The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Public Communications Contact Chairman | |
Queen's University | College/University | Graduate Degree Masters Business Admin | |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Angiotech Pharmaceuticals, Inc.
![]() Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Public Communications Contact | |
Perelman School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Cape Town | College/University | Undergraduate Degree Doctorate Degree | |
University of Victoria | College/University | Undergraduate Degree Masters Business Admin | |
Providence Health Care (Vancouver) | Director/Board Member Director/Board Member | ||
SERNOVA CORP. | Biotechnology | Director/Board Member Chairman | |
Centre for Molecular Medicine & Therapeutic | Director/Board Member Founder | ||
Michael Smith Foundation for Health Research
![]() Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
PERIMETER MEDICAL IMAGING AI, INC. | Medical Specialties | Director/Board Member Investor Relations Contact | |
Stanford University | College/University | Graduate Degree Corporate Officer/Principal | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Xenon Pharmaceuticals USA, Inc.
![]() Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Pharmaceuticals: Major | President Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aptalis Holdings, Inc.
![]() Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Aptalis Pharma LLC
![]() Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Pharmaceuticals: Major | Director of Finance/CFO | |
British Columbia Biotechnology Association | Director/Board Member | ||
ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Director/Board Member | |
DELIVRA HEALTH BRANDS INC. | Agricultural Commodities/Milling | Chairman | |
AstraZeneca Canada, Inc.
![]() AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Director of Finance/CFO | |
Ponderosa Capital, Inc.
![]() Ponderosa Capital, Inc. Investment ManagersFinance Ponderosa Capital, Inc. is a private company based in Vancouver, Canada. The company provides webnames.ca Canadian domain name registration and domain management services. Another domain registered by the company is currently under development and hosted by webnames.ca. Customers are advised to check back later for updates on the website. Frank A. Holler has been the CEO of the company since 2003. | Investment Managers | Chief Executive Officer | |
Redlen Technologies, Inc.
![]() Redlen Technologies, Inc. SemiconductorsElectronic Technology Redlen Technologies, Inc. engages in the manufacture of resolution Cadmium Zinc Telluride semiconductor radiation detectors. It enables performance detection and imaging equipment including Nuclear Cardiology, CT Scanning, Baggage Scanning and Dirty Bomb Detection. The company was founded in November 1999 and is headquartered in Saanichton, Canada. | Semiconductors | Director/Board Member |
Statistiques
Internationale
Canada | 25 |
Etats-Unis | 20 |
Royaume-Uni | 4 |
Afrique du Sud | 2 |
Israël | 2 |
Sectorielle
Health Technology | 31 |
Consumer Services | 11 |
Commercial Services | 3 |
Miscellaneous | 2 |
Process Industries | 2 |
Opérationnelle
Director/Board Member | 225 |
Corporate Officer/Principal | 97 |
Independent Dir/Board Member | 67 |
Chief Tech/Sci/R&D Officer | 44 |
Chairman | 39 |
Relations les plus connectées
Insiders | |
---|---|
Clarence Machado | 30 |
Frank Holler | 29 |
Michael Hayden | 27 |
Richard Scheller | 27 |
Simon Pimstone | 22 |
Mohammad Azab | 21 |
Brad Forth Forth | 20 |
Dawn Svoronos | 19 |
Michael Tarnow | 18 |
Jean-François Heitz | 18 |
Gary Patou | 17 |
Richard Levy | 16 |
Kelvin Neu | 15 |
Steven Gannon | 14 |
Paul Brennan | 14 |
- Bourse
- Insiders
- Shelley McCloskey
- Connexions Sociétés